Valvular Heart Disease in China
Cross-source consensus on Valvular Heart Disease in China from 1 sources and 4 claims.
1 sources · 4 claims
Evidence quality
Where it comes from
Highlighted claims
- The study examined sex differences in moderate-to-severe valvular heart disease among adults in China using a prospective multicentre hospital-based cohort. — Gender differences in clinical profiles, management and outcomes of valvular heart disease in China: insights from a nationwide cohort
- The cohort included 13,917 adults enrolled from 46 tertiary hospitals and regional cardiovascular referral centres in China between April and June 2018. — Gender differences in clinical profiles, management and outcomes of valvular heart disease in China: insights from a nationwide cohort
- Women made up 45.24% of the cohort, and the median patient age was 62 years. — Gender differences in clinical profiles, management and outcomes of valvular heart disease in China: insights from a nationwide cohort
- The findings apply primarily to hospital-based specialty care rather than the general population or untreated community cases. — Gender differences in clinical profiles, management and outcomes of valvular heart disease in China: insights from a nationwide cohort